CRITICAL SUCCESS FACTORS OF EFFECTIVE DRUG DEVELOPMENT PROCESS: AN ANALYTICAL STUDY

Authors

  • Dr Prashant Gahtori Assistant Professor,Department of Pharmacy , Graphic Era Hill University, Dehradun Uttarakhand India 248002 Author

DOI:

https://doi.org/10.61841/rb22zv69

Keywords:

Pharmaceutical industry, Drug development, Contemporary diseases, Science and Technology, Administration

Abstract

 This article is aimed to describe factors which are effective towards the success of drug discovery and their development process. According to the research, there is no single explanation on behalf of this discussion as the content outlines crucial factors on its enhancement. Drug development is very critical process, because it helps to treat contemporary diseases and fight the new ones which are within the human populace. Before a drug can reach to an affected person, it should consider successful and rigorous factors that encourage the pharmaceutical developmental programs decide whether it’s far safe, powerful towards treating the severe circumstances and also help them to, envision the correct dosage as well as the suitable administration path. The mentioned factors in the below section, are several outcome of this research therefore, such theories help pharmaceutical industry to study their capability techniques and encourage them to enhance medical development fulfilment prices and its productivity also. Advancement in sciences and technology is also helping this industry with many unique processes and level, from their ideation to development to its approval. There are many pharmaceutical drug development programs which are based on a global strategy that results to predictable expedited approval outcomes. 

Downloads

Download data is not yet available.

References

• Alanine, A., Nettekoven, M., Roberts, E., & Thomas, A. W. (2003). Lead generationenhancing the success of drug discovery by investing in the hit to lead

process. Combinatorial chemistry & high throughput screening, 6(1), 51-66.

• Corsini, A., & Ceska, R. (2011). Drug–drug interactions with statins: will pitavastatin

overcome the statins’ Achilles’ heel? Current medical research and opinion, 27(8),

1551-1562.

• Dias, D. A., Urban, S., & Roessner, U. (2012). A historical overview of natural

products in drug discovery. Metabolites, 2(2), 303-336.

• Hoelder, S., Clarke, P. A., & Workman, P. (2012). Discovery of small molecule

cancer drugs: successes, challenges, and opportunities. Molecular oncology, 6(2),

155-176.

• Hughes, J. P., Rees, S., Kalindjian, S. B., & Philpott, K. L. (2011). Principles of early

drug discovery. British journal of pharmacology, 162(6), 1239-1249.

• Kesselheim, A. S., & Darrow, J. J. (2015). FDA designations for therapeutics and

their impact on drug development and regulatory review outcomes. Clinical

Pharmacology & Therapeutics, 97(1), 29-36.

• Khanna, I. (2012). Drug discovery in pharmaceutical industry: productivity challenges

and trends. Drug discovery today, 17(19-20), 1088-1102.

• Mohs, R. C., & Greig, N. H. (2017). Drug discovery and development: Role of basic

biological research. Alzheimer's & Dementia: Translational Research & Clinical

Interventions, 3(4), 651-657.

• Naylor, S., & Chen, J. Y. (2010). Unraveling human complexity and disease with

systems biology and personalized medicine. Personalized medicine, 7(3), 275-289.

• O’Brien, M. K., Kolb, M., Connolly, T. J., McWilliams, J. C., & Sutherland, K.

(2011). Early chemical development at legacy Wyeth Research. Drug discovery

today, 16(1-2), 81-88.

• Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H.,

Lindborg, S. R., & Schacht, A. L. (2010). How to improve R&D productivity: the

pharmaceutical industry's grand challenge. Nature reviews Drug discovery, 9(3), 203-

214.

• Petrova, E. (2014). Innovation in the pharmaceutical industry: The process of drug

discovery and development. Innovation and Marketing in the Pharmaceutical

Industry: Emerging Practices, Research, and Policies, 19-81.

• Robinson, L. E., Stodden, D. F., Barnett, L. M., Lopes, V. P., Logan, S. W.,

Rodrigues, L. P., & D’Hondt, E. (2015). Motor competence and its effect on positive

developmental trajectories of health. Sports medicine, 45, 1273-1284.

• Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012). Diagnosing the

decline in pharmaceutical R&D efficiency. Nature reviews Drug discovery, 11(3),

191-200.

• Zurdo, J. (2013). Developability assessment as an early de-risking tool for

biopharmaceutical development. Pharmaceutical Bioprocessing, 1(1), 29-50

Downloads

Published

28.02.2021

How to Cite

Gahtori, P. (2021). CRITICAL SUCCESS FACTORS OF EFFECTIVE DRUG DEVELOPMENT PROCESS: AN ANALYTICAL STUDY. International Journal of Psychosocial Rehabilitation, 25(1), 715-722. https://doi.org/10.61841/rb22zv69